Subpial cortical demyelination is an important component of multiple sclerosis (MS) pathology contributing to disease progression, yet mechanism(s) underlying its development remain unclear. Compartmentalized inflammation involving the meninges may drive this type of injury. Given recent findings identifying substantial white matter (WM) lesion activity in patients with progressive MS, elucidating whether and how WM lesional activity relates to meningeal inflammation and subpial cortical injury is of interest. Using postmortem FFPE tissue blocks (range, 5–72 blocks; median, 30 blocks) for each of 27 patients with progressive MS, we assessed the relationship between meningeal inflammation, the extent of subpial cortical demyelination, and the state of subcortical WM lesional activity. Meningeal accumulations of T cells and B cells, but not myeloid cells, were spatially adjacent to subpial cortical lesions, and greater immune cell accumulation was associated with larger subpial lesion areas. Patients with a higher extent of meningeal inflammation harbored a greater proportion of active and mixed active/inactive WM lesions and an overall lower proportion of inactive and remyelinated WM lesions. Our findings support the involvement of meningeal lymphocytes in subpial cortical injury and point to a potential link between inflammatory subpial cortical demyelination and pathological mechanisms occurring in the subcortical WM.
Shanzeh M. Ahmed, Nina L. Fransen, Hanane Touil, Iliana Michailidou, Inge Huitinga, Jennifer L. Gommerman, Amit Bar-Or, Valeria Ramaglia
Title and authors | Publication | Year |
---|---|---|
A Window into New Insights on Progression Independent of Relapse Activity in Multiple Sclerosis: Role of Therapies and Current Perspective
Guerra T, Iaffaldano P |
International Journal of Molecular Sciences | 2025 |
T-bet+ CXCR3+ B cells drive hyperreactive B-T cell interactions in multiple sclerosis
Jelcic I, Naghavian R, Fanaswala I, Macnair W, Esposito C, Calini D, Han Y, Marti Z, Raposo C, Sarabia del Castillo J, Oldrati P, Erny D, Kana V, Zheleznyakova G, Al Nimer F, Tackenberg B, Reichen I, Khademi M, Piehl F, Robinson MD, Jelcic I, Sospedra M, Pelkmans L, Malhotra D, Reynolds R, Jagodic M, Martin R |
Cell Reports Medicine | 2025 |
Imaging of brain barrier inflammation and brain fluid drainage in human neurological diseases.
Okar SV, Fagiani F, Absinta M, Reich DS |
Cellular and molecular life sciences : CMLS | 2024 |
Synaptic injury in the inner plexiform layer of the retina is associated with progression in multiple sclerosis
Cordano C, Werneburg S, Abdelhak A, Bennett DJ, Beaudry-Richard A, Duncan GJ, Oertel FC, Boscardin WJ, Yiu HH, Jabassini N, Merritt L, Nocera S, Sin JH, Samana IP, Condor Montes SY, Ananth K, Bischof A, Nourbakhsh B, Hauser SL, Cree BA, Emery B, Schafer DP, Chan JR, Green AJ |
Cell reports. Medicine | 2024 |
New imaging markers in MS and related disorders: Smoldering inflammation and central vein sign
Hemond CC, Gaitán MI, Absinta M, Reich DS |
Neuroimaging Clinics of North America | 2024 |
Digital Pathology Identifies Associations between Tissue Inflammatory Biomarkers and Multiple Sclerosis Outcomes
Cooze B, Neal J, Vineed A, Oliveira JC, Griffiths L, Allen KH, Hawkins K, Yadanar H, Gerhards K, Farkas I, Reynolds R, Howell O |
Cells | 2024 |
The contribution of tumor necrosis factor to multiple sclerosis: a possible role in progression independent of relapse?
Mazziotti V, Crescenzo F, Turano E, Guandalini M, Bertolazzo M, Ziccardi S, Virla F, Camera V, Marastoni D, Tamanti A, Calabrese M |
Journal of neuroinflammation | 2024 |
A glia-enriched stem cell 3D model of the human brain mimics the glial-immune neurodegenerative phenotypes of multiple sclerosis
Fagiani F, Pedrini E, Taverna S, Brambilla E, Murtaj V, Podini P, Ruffini F, Butti E, Braccia C, Andolfo A, Magliozzi R, Smirnova L, Kuhlmann T, Quattrini A, Calabresi PA, Reich DS, Martino G, Panina-Bordignon P, Absinta M |
Cell Reports Medicine | 2024 |
Intrathecal IgG and IgM synthesis correlates with neurodegeneration markers and corresponds to meningeal B cell presence in MS.
Rodriguez-Mogeda C, van Gool MM, van der Mast R, Nijland R, Keasberry Z, van de Bovekamp L, van Delft MA, Picon C, Reynolds R, Killestein J, Teunissen CE, de Vries HE, van Egmond M, Witte ME |
Scientific reports | 2024 |
Imaging Outcomes for Phase 2 Trials Targeting Compartmentalized Inflammation
Gaitán MI, Marquez RV, Ayerbe J, Reich DS |
Multiple sclerosis (Houndmills, Basingstoke, England) | 2024 |
Multiple sclerosis: 2023 update.
Kuhlmann T, Antel J |
Free neuropathology | 2023 |
Meningeal inflammation as a driver of cortical grey matter pathology and clinical progression in multiple sclerosis.
Magliozzi R, Howell OW, Calabrese M, Reynolds R |
Nature reviews. Neurology | 2023 |
A Dual Role of Osteopontin in Modifying B Cell Responses
Chunder R, Schropp V, Marzin M, Amor S, Kuerten S |
Biomedicines | 2023 |
Editorial: Complement in nervous system disease
Michailidou I, Fluiter K, Boziki M, Grigoriadis N, Baas F |
Frontiers in cellular neuroscience | 2023 |
Cross-talk between B cells, microglia and macrophages, and implications to central nervous system compartmentalized inflammation and progressive multiple sclerosis.
Touil H, Li R, Zuroff L, Moore CS, Healy L, Cignarella F, Piccio L, Ludwin S, Prat A, Gommerman J, Bennett FC, Jacobs D, Benjamins JA, Lisak RP, Antel JP, Bar-Or A |
EBioMedicine | 2023 |
Highly Sensitive 3-Tesla Real Inversion Recovery MRI Detects Leptomeningeal Contrast Enhancement in Chronic Active Multiple Sclerosis: Real-IR Detects Leptomeningeal Enhancement in MS.
Okar SV, Dieckhaus H, Beck ES, Gaitán MI, Norato G, Pham DL, Absinta M, Cortese IC, Fletcher A, Jacobson S, Nair G, Reich DS |
Investigative Radiology | 2023 |
Age-dependent grey matter demyelination is associated with leptomeningeal neutrophil accumulation
Michelle Zuo, Naomi M Fettig, Louis-Philippe Bernier, Elisabeth Pössnecker, Shoshana Spring, Annie Pu, Xianjie I. Ma, Dennis SW Lee, Lesley A. Ward, Anshu Sharma, Jens Kuhle, John G. Sled, Anne-Katrin Pröbstel, Brian A. MacVicar, Lisa C Osborne, Jennifer Gommerman, Valeria Ramaglia |
JCI Insight | 2022 |
Autoreactive lymphocytes in multiple sclerosis: Pathogenesis and treatment target
Liu R, Du S, Zhao L, Jain S, Sahay K, Rizvanov A, Lezhnyova V, Khaibullin T, Martynova E, Khaiboullina S, Baranwal M |
Frontiers in immunology | 2022 |
Single-Cell Analysis to Better Understand the Mechanisms Involved in MS.
Dugast E, Shah S, Laplaud DA |
International journal of molecular sciences | 2022 |
Emerging Potential of the Phosphodiesterase (PDE) Inhibitor Ibudilast for Neurodegenerative Diseases: An Update on Preclinical and Clinical Evidence
Angelopoulou E, Pyrgelis ES, Piperi C |
Molecules (Basel, Switzerland) | 2022 |